Patent details

EP2252301 Title: USE OF ULIPRISTAL FOR TREATING UTERINE FIBROIDS

Basic Information

Publication number:
EP2252301
PCT Application Number:
PCT/EP/2009/050961
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP097063473
PCT Publication Number:
WO/2009/095418
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF ULIPRISTAL FOR TREATING UTERINE FIBROIDS
French Title of Invention:
PROCÉDÉ DE TRAITEMENT DES FIBROMES UTÉRINS
German Title of Invention:
VERWENDUNG VON ULIPRISTAL ZUR BEHANDLUNG VON GEBÄRMUTTERFIBROIDEN
SPC Number:

Dates

Filing date:
28/01/2009
Grant date:
11/12/2013
EP Publication Date:
11/12/2013
PCT Publication Date:
06/08/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/11/2010
EP B1 Publication Date:
11/12/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/01/2029
Renunciation date:
Revocation date:
23/11/2020
Annulment date:

Owner

From:
28/01/2009
 
 

Name:
Laboratoire HRA Pharma
Address:
15, rue Béranger, 75003 Paris, France (FR)

Name:
THE U.S.A. AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Address:
OFFICE OF TECHNOLOGY TRANSFER NATIONAL INSTITUTES OF HEALTH, BETHESDA, MD 20892-7660, United States (US)

Agent

Name:
VALIPAT
From:
06/02/2014
Address:
Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)
To:

Inventor

1

Name:
GAINER Erin
Address:
France (FR)

2

Name:
NIEMAN Lynnette
Address:
United States (US)

3

Name:
ULMANN André
Address:
France (FR)

4

Name:
BLITHE Diana
Address:
United States (US)

Priority

Priority Number:
21610
Priority Date:
29/01/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/57;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2021/09
Publication date:
03/08/2021
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:
202130
Publication date:
28/07/2021
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
22/01/2020
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CABINET BECKER & ASSOCIES
Filing date Document type Number of pages